Swipe the table sideways for more columns.

TrialConditionsStatusPhaseUpdatedMore infoNCT ID
A Phase 1/2 Study of the Safety and Efficacy of BRX011 Oral Administration Once Daily in Subjects With Geographic Atrophy Secondary to Age-Related Macular DegenerationGeographic Atrophy, eye disorder, macular degeneration, retinal degeneration, retinal disorderRecruitingPhase 1 / Phase 22026-09-23NCT07029945

1 results · Page 1 of 1

Swipe the table sideways for more columns.

OrganizationsLinked trials
Biojiva LLC2

17 results · Page 1 of 1

Swipe the table sideways for more columns.

Research sitesCityCountryLinked trials
Associated Retina ConsultantsPhoenixUnited States21
Associated Retina Consultants - PHXGilbertUnited States1
Centre for Eye Research Australia (CERA)East MelbourneAustralia2
Eye Clinic Albury WodongaAlburyAustralia6
Nexus Eye CareBaulkham HillsAustralia1
Retina & Macula SpecialistsHurstvilleAustralia1
Retina Associates of ClevelandClevelandUnited States1
Retina Associates of Cleveland - BeachwoodBeachwoodUnited States2
Retina Associates of Cleveland - Middleburg HeightsMiddleburg HeightsUnited States1
Retina Research Center of Southern UtahSt. GeorgeUnited States2
Retina Research Institute of TexasAbileneUnited States17
Retina Specialists of Mississippi - HattiesburgHattiesburgUnited States1
Retina Specialists VictoriaRowvilleAustralia5
Sierra Eye AssociatesRenoUnited States30
Spokane Eye ClinicSpokaneUnited States3
Sydney Eye HospitalSydneyAustralia13
Valley Retina Institute, PAMcAllenUnited States4